HBA1C
发表于 2025-3-21 18:47:29
书目名称Melanoma in Clinical Practice影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0630300<br><br> <br><br>书目名称Melanoma in Clinical Practice影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0630300<br><br> <br><br>书目名称Melanoma in Clinical Practice网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0630300<br><br> <br><br>书目名称Melanoma in Clinical Practice网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0630300<br><br> <br><br>书目名称Melanoma in Clinical Practice被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0630300<br><br> <br><br>书目名称Melanoma in Clinical Practice被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0630300<br><br> <br><br>书目名称Melanoma in Clinical Practice年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0630300<br><br> <br><br>书目名称Melanoma in Clinical Practice年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0630300<br><br> <br><br>书目名称Melanoma in Clinical Practice读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0630300<br><br> <br><br>书目名称Melanoma in Clinical Practice读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0630300<br><br> <br><br>
CLIFF
发表于 2025-3-21 20:42:02
http://reply.papertrans.cn/64/6303/630300/630300_2.png
乏味
发表于 2025-3-22 01:36:52
http://reply.papertrans.cn/64/6303/630300/630300_3.png
墙壁
发表于 2025-3-22 05:15:41
Adjuvant Systemic Therapy for Stage III Melanomahile both adjuvant BRAF/MEK-targeted therapy and checkpoint inhibitor therapy have been shown to improve the outcome of stage III patients, a 1-year course of checkpoint inhibitor therapy is commonly considered the standard of care for most stage III patients.
老人病学
发表于 2025-3-22 09:37:16
Book 2021sis, treatment and prevention of melanoma. It features easy to digest instructional text that describes a variety of techniques for detecting and staging melanoma including total body photography. Surgical, radiation and systemic therapy treatment options as well as prevention strategies are also co
熟练
发表于 2025-3-22 14:05:18
Epidemiology of MelanomaSA, its mortality finally seems to be leveling off in many places. Lessons learned from one country may be useful to others, as primary and secondary prevention campaigns are tried. Here, we discuss current patterns in melanoma incidence and mortality, as well as trends in tumor thickness and the most common melanoma subtypes.
AVOW
发表于 2025-3-22 19:02:23
Evolution of Neoadjuvant Therapy in Melanomae have been able to better define the extent of surgical resection necessary for improved disease-free and overall survival. This chapter will review the benefits of neoadjuvant combination therapy, monotherapy, targeted therapy and how each is best achieved in concert with surgical resection.
CRAMP
发表于 2025-3-22 23:42:11
http://reply.papertrans.cn/64/6303/630300/630300_8.png
狗窝
发表于 2025-3-23 01:38:32
http://reply.papertrans.cn/64/6303/630300/630300_9.png
DALLY
发表于 2025-3-23 07:52:06
Adjuvant Radiation Therapy for Stage III Melanomaprimary adjuvant treatment modality in Stage III and Stage IV disease. In the era of immunotherapy, we discuss the role and benefit of adjuvant RT. We also discuss the role of RT in desmoplastic melanoma.